Arcellx Tender Offer Secures 77.2% Acceptance, Clearing Path for Gilead Acquisition

The tender offer for Arcellx expired at 5:00 p.m. Eastern Time on April 27, 2026, concluding a defined acquisition window. This process captured 38,795,604 valid tenders, representing 77.2% of the company’s outstanding shares when combined with existing holdings by the parent.

Gilead’s subsidiary and parent now anticipate finalizing the acquisition on April 28, 2026, via a merger that bypasses a stockholder vote. The deal includes $115 per share in cash and a contingent value right tied to future sales milestones.

What to watch next is the regulatory clearance that will confirm the transaction’s completion.